Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis-Reference-Cited by-同舟云学术

Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis

Published:2008-04-09 Issue:3 Volume:63 Page:433-439
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Seo Hee Yeon,Kim Dae Sik,Choi Yoon Seok,Sung Hwa Jung,Park Kyong Hwa,Choi In Keun,Kim Seok Jin,Oh Sang Cheul,Seo Jae Hong,Choi Chul Won,Kim Byung Soo,Shin Sang Won,Kim Yeul Hong,Kim Jun Suk

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-008-0753-3.pdf

Reference29 articles.

1. Shin HR, Won YJ, Jung KW et al (2005) Nationwide cancer incidence in Korea, 1999–2001; first result using the national cancer incidence database. Cancer Res Treat 37:325–331

2. Epelbaum R, Haim N, Stein M, Cohen Y, Robinson E (1987) Treatment of advanced gastric cancer with DDP (cisplatin), adriamycin, and 5-fluorouracil (DAF). Oncology 44:201–206

3. Lopez M, Di Lauro L, Papaldo P, Conti EM (1986) Treatment of advanced measurable gastric carcinoma with 5-fluorouracil, adriamycin, and BCNU. Oncology 43:288–291

4. Becouarn Y, Agostini C, Trufflandier N, Boulanger V (2001) Oxaliplatin: available data in non-colorectal gastrointestinal malignancies. Crit Rev Oncol Hematol 40:265–272

5. Raymond E, Faivre S, Woynarowski JM, Chaney SG (1998) Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol 25:4–12

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811);Future Science OA;2021-08

2. Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan;Gastric Cancer;2018-04-16

3. FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis;Anticancer Research;2017-12-03

4. Blood neutrophil–lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4;Medical Oncology;2014-11-04

5. Second-Line Irinotecan after Cisplatin, Fluoropyrimidin and Docetaxel for Chemotherapy of Metastatic Gastric Cancer;Asian Pacific Journal of Cancer Prevention;2012-06-30